SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-018412
Filing Date
2018-01-24
Accepted
2018-01-24 16:19:56
Documents
6
Period of Report
2018-01-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d531161d8k.htm 8-K 19215
2 EXHIBIT 99.1 d531161dex991.htm EX-99.1 11994
3 EXHIBIT 99.2 d531161dex992.htm EX-99.2 5966
4 EXHIBIT 99.3 d531161dex993.htm EX-99.3 50756
5 EXHIBIT 99.4 d531161dex994.htm EX-99.4 38348
6 GRAPHIC g531161g74z28.jpg GRAPHIC 121600
  Complete submission text file 0001193125-18-018412.txt   295103
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 18545409
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1